News

Moderna, Inc. (MRNA) Withdraws Application for COVID-flu Combination Vaccine
Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) ...
Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19
CAMBRIDGE, MA / ACCESS Newswire / May 21, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U ...
Medical Marketing & Media3d
FDA to limit COVID boosters, Trump touts ‘Most Favored Nation’ framework
Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing ...
Moderna Pulls FDA Application for Flu-Covid Combo Vaccine
Moderna has withdrawn its pending application for a combination vaccine for both the flu and Covid-19, saying it will resubmit later this year once it has more data.
Amid new COVID-19 wave, FDA places millions at risk by restricting access to vaccines
The FDA’s new policy limits COVID-19 vaccine eligibility to older adults and high-risk groups, excluding millions from ...
Moderna Stock Jumps on New FDA COVID-19 Booster Guidelines
Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID ...